Cylene Pharmaceuticals Overview
- Website
- cylenepharma.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2001
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Cylene Pharmaceuticals
Cylene Pharmaceuticals ceased operation in 2013. It was a clinical stage private company designing and developing small molecule drugs against newly validated cancer targets. Cylene’s leadership in exploiting CK2 pathways enabled rational drug combinations for improved treatment outcomes against many cancer indications. The Company’s Pol I program provided a non-genotoxic mechanism for activating p53 to kill cancer cells.
Cylene Pharmaceuticals Contact Details
Employees by Management Level
Individual contributor
2 profiles
Associate / junior
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 1 | 1 | 0 |
Compare Similar Companies to Cylene Pharmaceuticals
Newfund
Venture Capital And Private Equity Principals
Nosis Bio
Biotechnology Research
ARJ Pharmaceuticals LLC
Pharmaceutical Manufacturing
Best + Well
Pharmaceutical Manufacturing
Mullan Pharmaceutical Inc.
Pharmaceutical Manufacturing
Pimera Therapeutics
Biotechnology
AEPEG
Industry Associations
The Data Republic (Acquired by Kantar)
It Services And It Consulting
TildenBio
Biotechnology Research
Vildin
Technology, Information And Internet